Consensus Shanghai Henlius Biotech, Inc.

Equities

Market Closed - Hong Kong S.E. Other stock markets 04:08:35 2024-05-22 am EDT			5-day change	1st Jan Change
18.84 ^HKD	+4.67%		-.--%	+35.54%

May. 24	Organon, Henlius' Denosumab Biosimilar HLX14 Gets European Validation	MT
May. 24	Henlius' EU Marketing Application for Denosumab Biosimilar Accepted and Validated by Regulator	MT

d9.wZ9V-7tUgbfgz2Fug3T5Ai3zj8j_HPoNGTNumKrwVak.pvgktPojx9O6uQ8l0BGfRlqftqC5eohcbV8d4OyZL8uIxSeu7h_71M26WQ~adf02ca8839249cfd404954f2351a4f1

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

17.47 CNY

Average target price

16.7 CNY

Spread / Average Target

-4.42%

High Price Target

23.05 CNY

Spread / Highest target

+31.91%

Low Price Target

8.352 CNY

Spread / Lowest Target

-52.20%

Trading Rating

Investor Rating

ESG Refinitiv